These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24748338)

  • 1. Does cabergoline help in decreasing endometrioma size compared to LHRH agonist? A prospective randomized study.
    Hamid AM; Madkour WA; Moawad A; Elzaher MA; Roberts MP
    Arch Gynecol Obstet; 2014 Oct; 290(4):677-82. PubMed ID: 24748338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of efficacy of bromocriptine and cabergoline to GnRH agonist in a rat endometriosis model.
    Ercan CM; Kayaalp O; Cengiz M; Keskin U; Yumusak N; Aydogan U; Ide T; Ergun A
    Arch Gynecol Obstet; 2015 May; 291(5):1103-11. PubMed ID: 25367601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GnRH agonist and antagonist protocols for stage I-II endometriosis and endometrioma in in vitro fertilization/intracytoplasmic sperm injection cycles.
    Pabuccu R; Onalan G; Kaya C
    Fertil Steril; 2007 Oct; 88(4):832-9. PubMed ID: 17428479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of add-back treatment with tibolone (Livial) on patients treated with the gonadotropin-releasing hormone agonist triptorelin (Decapeptyl).
    Lindsay PC; Shaw RW; Bennink HJ; Kicovic P
    Fertil Steril; 1996 Feb; 65(2):342-8. PubMed ID: 8566259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of ovarian hyperstimulation syndrome in GnRH agonist IVF cycles in moderate risk patients: randomized study comparing hydroxyethyl starch versus cabergoline and hydroxyethyl starch.
    Matorras R; Andrés M; Mendoza R; Prieto B; Pijoan JI; Expósito A
    Eur J Obstet Gynecol Reprod Biol; 2013 Oct; 170(2):439-43. PubMed ID: 23932181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized study comparing the side effects and hormonal status of triptorelin and leuprorelin following conservative laparoscopic surgery for ovarian endometriosis in Chinese women.
    Li Z; Zhang HY; Zhu YJ; Hu YJ; Qu PP
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():164-8. PubMed ID: 25461372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of triptorelin versus placebo on the symptoms of endometriosis.
    Bergqvist A; Bergh T; Hogström L; Mattsson S; Nordenskjöld F; Rasmussen C
    Fertil Steril; 1998 Apr; 69(4):702-8. PubMed ID: 9548161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-acting triptorelin for the treatment of endometriosis.
    Choktanasiri W; Boonkasemsanti W; Sittisomwong T; Kunathikom S; Suksompong S; Udomsubpayakul U; Rojanasakul A
    Int J Gynaecol Obstet; 1996 Sep; 54(3):237-43. PubMed ID: 8889631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of long-term treatment with the luteinizing hormone-releasing hormone (LHRH) agonist Decapeptyl and the LHRH antagonist Cetrorelix on the levels of pituitary LHRH receptors and their mRNA expression in rats.
    Horvath JE; Bajo AM; Schally AV; Kovacs M; Herbert F; Groot K
    Proc Natl Acad Sci U S A; 2002 Nov; 99(23):15048-53. PubMed ID: 12409615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized study comparing triptorelin or expectant management following conservative laparoscopic surgery for symptomatic stage III-IV endometriosis.
    Loverro G; Carriero C; Rossi AC; Putignano G; Nicolardi V; Selvaggi L
    Eur J Obstet Gynecol Reprod Biol; 2008 Feb; 136(2):194-8. PubMed ID: 17178185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luteinizing hormone-releasing hormone agonist triptorelin and antagonist cetrorelix inhibit EGF-induced c-fos expression in human gynecological cancers.
    Gründker C; Völker P; Schulz KD; Emons G
    Gynecol Oncol; 2000 Aug; 78(2):194-202. PubMed ID: 10926802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Efficacy of Postoperative Cyclic Oral Contraceptives after Gonadotropin-Releasing Hormone Agonist Therapy to Prevent Endometrioma Recurrence in Adolescents.
    Seo JW; Lee DY; Yoon BK; Choi D
    J Pediatr Adolesc Gynecol; 2017 Apr; 30(2):223-227. PubMed ID: 27744096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triptorelin for the treatment of endometriosis.
    Leone Roberti Maggiore U; Scala C; Remorgida V; Venturini PL; Del Deo F; Torella M; Colacurci N; Salvatore S; Ferrari S; Papaleo E; Candiani M; Ferrero S
    Expert Opin Pharmacother; 2014 Jun; 15(8):1153-79. PubMed ID: 24832495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study of subcutaneous administration of gonadotropin-releasing hormone agonist every six weeks in girls with idiopathic central precocious puberty].
    Liang Y; Wei H; Zhang JL; Hou L; Luo XP
    Zhonghua Er Ke Za Zhi; 2004 Nov; 42(11):845-9. PubMed ID: 15631714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The age-related recurrence of endometrioma after conservative surgery.
    Seo JW; Lee DY; Yoon BK; Choi D
    Eur J Obstet Gynecol Reprod Biol; 2017 Jan; 208():81-85. PubMed ID: 27894033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gonadotropin-releasing agonist in the therapy of patients with laparoscopically confirmed endometriosis].
    Pŭnevska M; Filipov E; Nalbanski A; Nalbanski B
    Akush Ginekol (Sofiia); 2004; 43 Suppl 4():58-60. PubMed ID: 15673017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effect of gonadotropin-releasing hormone analog (Diphereline) and Cabergoline (Dostinex) treatment on uterine myoma regression.
    Melli MS; Farzadi L; Madarek EO
    Saudi Med J; 2007 Mar; 28(3):445-50. PubMed ID: 17334477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis.
    Novella-Maestre E; Carda C; Noguera I; Ruiz-Saurí A; García-Velasco JA; Simón C; Pellicer A
    Hum Reprod; 2009 May; 24(5):1025-35. PubMed ID: 19189995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relapse after conservative surgery combined with triptorelin acetate versus conservative surgery only in women with focal adenomyosis: study protocol for a multicenter, prospective, randomized controlled trial.
    Wang W; Ma X; Zhang W; Li Z; Wang Y; Yu Z; Zhang C; Hong L; Luo R; Xing H; Wang W; Yue Q; Wei J; Zhang M; Wang S
    Trials; 2020 Apr; 21(1):364. PubMed ID: 32345377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An open and randomized study comparing the efficacy of standard danazol and modified triptorelin regimens for postoperative disease management of moderate to severe endometriosis.
    Wong AY; Tang L
    Fertil Steril; 2004 Jun; 81(6):1522-7. PubMed ID: 15193471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.